SHILOH v. PHILADELPHIA VASCULAR INSTITUTE LLC

CourtDistrict Court, E.D. Pennsylvania
DecidedMarch 29, 2024
Docket2:18-cv-05458
StatusUnknown

This text of SHILOH v. PHILADELPHIA VASCULAR INSTITUTE LLC (SHILOH v. PHILADELPHIA VASCULAR INSTITUTE LLC) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SHILOH v. PHILADELPHIA VASCULAR INSTITUTE LLC, (E.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

UNITED STATES OF AMERICA, : CIVIL ACTION ex rel. AARON SHILOH, M.D., FSIR : Plaintiff : NO. 18-5458 : v. : : PHILADELPHIA VASCULAR : INSTITUTE LLC, et al. : Defendants :

NITZA I. QUIÑONES ALEJANDRO, J. MARCH 29, 2024

MEMORANDUM OPINION

INTRODUCTION Realtor Dr. Aaron Shiloh filed this qui tam1 action against Defendants James McGuckin, M.D., (“Defendant McGuckin”) and Philadelphia Vascular Institute, LLC, asserting violations of the False Claims Act (the “FCA”), 31 U.S.C. § 3729 et seq. On February 28, 2023, the United States of America2 (the “Government”) filed a notice of intervention, indicating its decision to intervene on behalf of the relator, (ECF 27), and on May 1, 2023, filed the complaint in intervention against Defendant McGuckin and his practices and management companies,3

1 “Qui tam is short for the Latin phrase qui tam pro domino rege quam pro se ipso in hac parte sequitur, which means ‘who pursues this action on our Lord the King’s behalf as well as his own.’” Vt. Agency of Nat. Res. v. United States ex rel. Stevens, 529 U.S. 765, 768 n.1 (2000). A private person, called a relator, brings an action “’for the person and for the United States Government against’ the alleged false claimant, ‘in the name of the Government.’” Id. at 769 (quoting 31 U.S.C. § 3730(b)(1)).

2 The Government brings this action on behalf of the United States Department of Health and Human Services (“HHS”); the Centers for Medicare & Medicaid Services (“CMS”), which administers the Medicare program (“Medicare”), 42 U.S.C. §§ 1395 et seq.; and the United States Office of Personnel Management (“OPM”), which administers the Federal Employee Health Benefits Program (“FEHBP”).

3 The Government additionally brings this action against Defendants Philadelphia Vascular Institute, LLC (“Defendant PVI”) and Pennsylvania Vascular Institute, PC (“Defendant PA PC”) (collectively, “Management Defendants”); and Lehigh Valley Vascular Institute LLC (“Defendant LVVI”), PA Vascular (collectively “Defendants”), asserting claims under the FCA for, inter alia, knowingly submitting or causing the submission of false claims for reimbursement to federal health care programs for medically unnecessary invasive vascular procedures, knowingly making false statements to the government related to those procedures, and violating the Anti-Kickback Statute, 42 U.S.C. §§ 1320a-7b(b), (g), (ECF 32).

Before the Court is Defendants’ motion to dismiss filed pursuant to Federal Rule of Civil Procedure (“Rule”) 12(b)(6) and Rule 9(b). (ECF 36). The Government opposes the motion. (ECF 40). The issues raised in the motion have been fully briefed and are ripe for disposition.4 For the reasons set forth, Defendants’ motion is denied. BACKGROUND

When ruling on a motion to dismiss, this Court must accept as true the well-pleaded allegations in the Government’s complaint. See Fowler v. UPMC Shadyside, 578 F.3d 203, 210 (3d Cir. 2009). The facts relevant to the motion to dismiss are summarized as follows:5 Overview of Medicare Payment System6 Medicare is a federal program administered by the Centers for Medicare & Medicaid Services (“CMS”), an agency within the Department of Health and Human Services (“HHS”). The Medicare program consists of four parts: A, B, C, and D. Only Part B is relevant here. Medicare Part B covers the cost of outpatient care, including physician services and ancillary services, furnished by physicians and other providers and suppliers.

Institute LLC (“Defendant PAVI”), Peripheral Vascular Institute of Philadelphia, LLC (“Defendant PVIP”), and Main Line Vascular Institute LLC (“Defendant MLVI”) (collectively, “Defendant Practices”). The Government alleges Defendant McGuckin owns 100% of Management Defendants, and that Defendant PA PC owns 100% of Defendant Practice.

4 This Court has also considered Defendants’ reply. (ECF 41).

5 These facts are drawn from the Government’s complaint in intervention. (ECF 32).

6 (See Compl., ECF 32, at § III (B)). Medicare pays only for services that are actually rendered and which are “reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.” 42 U.S.C. § 1395y(a)(1)(A). To this end, Medicare providers must assure that their services are rendered “economically and only when, and to the extent, medically necessary,” and that their services are “of a quality which meets professionally recognized standards of health care.” 42 U.S.C. §§ 1320c-5(a)(l)-(2).

After performing a Part B service, providers are required to submit a claim form to the CMS certifying, among other things, that “the services shown on this form were medically indicated and necessary for the health of the patient[.]” See CMS Form 1500. Relying on the veracity of these certifications, the CMS makes Medicare payments retroactively, i.e., they reimburse Part B providers. When submitting a claim form, the provider includes a five-digit code (“CPT code”) that identifies, for example, the diagnosis, services rendered, and the unique billing identification number. Providing accurate CPT codes on the claim form is a condition of payment from Medicare.

As a general matter, Medicare Part B covers 80% of the reasonable cost of medical services; the remaining 20% is owed by the beneficiary as a copayment obligation. Except in rare circumstances, providers are required to make a reasonable collection effort for the full 20% copayment from Medicare beneficiaries or their secondary insurers.

Factual Allegations

Defendant McGuckin is an interventional radiologist. He owns and operates multiple vascular practices across the country, including the Defendant Practices and Management Defendants. Between 2016 and 2019, Defendant McGuckin and the Defendant Practices were providing endovascular services to Medicare and FEHBP beneficiaries. Defendant McGuckin has been registered as a Medicare provider in Pennsylvania since at least 2010. Defendant Practices and Management Defendants are also registered Medicare providers in Pennsylvania.

Defendant McGuckin instructed physicians at Defendant Practices to screen all dialysis patients for Peripheral Artery Disease (“PAD”).7 He also instructed physicians to perform intravenous ultrasounds on every Medicare patient instead of using less invasive diagnostic measures. Defendants also scheduled follow up tests of asymptomatic patients at regular intervals. Defendants performed most procedures, including angioplasties, atherectomies, and stent implantations, without any prior non-invasive imaging or assessment of relevant medical histories

7 Peripheral Artery Disease (“PAD”) is the narrowing or blockage of peripheral arteries and the consequent reduction of blood flow to the legs. The standards of care for the treatment of PAD depend almost entirely on a patient’s symptoms.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hynson v. City of Chester, Legal Department
864 F.2d 1026 (Third Circuit, 1988)
Rodriguez v. Our Lady of Lourdes Medical Center
552 F.3d 297 (Third Circuit, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Thomas Foglia v. Renal Ventures Management
754 F.3d 153 (Third Circuit, 2014)
United States Ex Rel. Petratos v. Genentech Inc.
855 F.3d 481 (Third Circuit, 2017)
United States Ex Rel. Polukoff v. St. Mark's Hosp.
895 F.3d 730 (Tenth Circuit, 2018)
USA, ex rel. v. UPMC
946 F.3d 162 (Third Circuit, 2019)
Victoria Druding v. Care Alternatives
952 F.3d 89 (Third Circuit, 2020)
Xiulu Ruan v. United States
597 U.S. 450 (Supreme Court, 2022)
Bartol v. Barrowclough
251 F. Supp. 3d 855 (E.D. Pennsylvania, 2017)
Rosenberg v. C.R. Bard, Inc.
387 F. Supp. 3d 572 (E.D. Pennsylvania, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
SHILOH v. PHILADELPHIA VASCULAR INSTITUTE LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shiloh-v-philadelphia-vascular-institute-llc-paed-2024.